Birth of MHC-defined rhesus monkeys produced by assisted reproductive technology

R. Dee Schramm, Ann Marie Paprocki, David Watkins

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

One of the best animal approaches for testing HIV vaccines is the challenge of vaccinated rhesus macaques with SHIV or SIV. Production of rhesus macaques in which all of the MHC class I and II alleles are known represents an opportunity to characterize the entire immune response to SIV and should be an invaluable resource for understanding pathogenesis and vaccine-induced immune responses. Unfortunately, there are few MHC-defined rhesus macaques available for vaccine research. Selective breeding supports the production of limited numbers of macaques that express particular MHC class I alleles. If both parents express the allele of interest, only three quarters of the offspring will express the same allele. However, assisted reproductive technologies, such as in vitro fertilization (IVF) and embryo transfer, can be used for production of MHC-defined macaques, expressing multiple MHC class I and II molecules for which SIV peptides, tetramers and ELISPOT assays exist. Here, we report the birth of MHC-defined rhesus monkeys produced by assisted reproductive technology. Continued improvements in assisted reproductive technologies in rhesus monkeys will enable us to develop a unique prototypic animal production program for the creation of MHC-defined and genetically-identical monkeys for vaccine research.

Original languageEnglish
Pages (from-to)603-607
Number of pages5
JournalVaccine
Volume20
Issue number3-4
DOIs
StatePublished - Nov 12 2001
Externally publishedYes

Fingerprint

assisted reproductive technologies
Assisted Reproductive Techniques
Macaca mulatta
Parturition
Alleles
vaccines
alleles
Vaccines
Macaca
immune response
Enzyme-Linked Immunospot Assay
AIDS Vaccines
Embryo Transfer
in vitro fertilization
embryo transfer
Fertilization in Vitro
selection methods
animal production
Research
Haplorhini

Keywords

  • Assisted reproductive technology
  • MHC-defined monkeys
  • SIV vaccine

ASJC Scopus subject areas

  • Immunology
  • Microbiology
  • Virology
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)

Cite this

Birth of MHC-defined rhesus monkeys produced by assisted reproductive technology. / Schramm, R. Dee; Paprocki, Ann Marie; Watkins, David.

In: Vaccine, Vol. 20, No. 3-4, 12.11.2001, p. 603-607.

Research output: Contribution to journalArticle

Schramm, R. Dee ; Paprocki, Ann Marie ; Watkins, David. / Birth of MHC-defined rhesus monkeys produced by assisted reproductive technology. In: Vaccine. 2001 ; Vol. 20, No. 3-4. pp. 603-607.
@article{cd155d45b5c74e09aa2993191d09b2e8,
title = "Birth of MHC-defined rhesus monkeys produced by assisted reproductive technology",
abstract = "One of the best animal approaches for testing HIV vaccines is the challenge of vaccinated rhesus macaques with SHIV or SIV. Production of rhesus macaques in which all of the MHC class I and II alleles are known represents an opportunity to characterize the entire immune response to SIV and should be an invaluable resource for understanding pathogenesis and vaccine-induced immune responses. Unfortunately, there are few MHC-defined rhesus macaques available for vaccine research. Selective breeding supports the production of limited numbers of macaques that express particular MHC class I alleles. If both parents express the allele of interest, only three quarters of the offspring will express the same allele. However, assisted reproductive technologies, such as in vitro fertilization (IVF) and embryo transfer, can be used for production of MHC-defined macaques, expressing multiple MHC class I and II molecules for which SIV peptides, tetramers and ELISPOT assays exist. Here, we report the birth of MHC-defined rhesus monkeys produced by assisted reproductive technology. Continued improvements in assisted reproductive technologies in rhesus monkeys will enable us to develop a unique prototypic animal production program for the creation of MHC-defined and genetically-identical monkeys for vaccine research.",
keywords = "Assisted reproductive technology, MHC-defined monkeys, SIV vaccine",
author = "Schramm, {R. Dee} and Paprocki, {Ann Marie} and David Watkins",
year = "2001",
month = "11",
day = "12",
doi = "10.1016/S0264-410X(01)00336-X",
language = "English",
volume = "20",
pages = "603--607",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "3-4",

}

TY - JOUR

T1 - Birth of MHC-defined rhesus monkeys produced by assisted reproductive technology

AU - Schramm, R. Dee

AU - Paprocki, Ann Marie

AU - Watkins, David

PY - 2001/11/12

Y1 - 2001/11/12

N2 - One of the best animal approaches for testing HIV vaccines is the challenge of vaccinated rhesus macaques with SHIV or SIV. Production of rhesus macaques in which all of the MHC class I and II alleles are known represents an opportunity to characterize the entire immune response to SIV and should be an invaluable resource for understanding pathogenesis and vaccine-induced immune responses. Unfortunately, there are few MHC-defined rhesus macaques available for vaccine research. Selective breeding supports the production of limited numbers of macaques that express particular MHC class I alleles. If both parents express the allele of interest, only three quarters of the offspring will express the same allele. However, assisted reproductive technologies, such as in vitro fertilization (IVF) and embryo transfer, can be used for production of MHC-defined macaques, expressing multiple MHC class I and II molecules for which SIV peptides, tetramers and ELISPOT assays exist. Here, we report the birth of MHC-defined rhesus monkeys produced by assisted reproductive technology. Continued improvements in assisted reproductive technologies in rhesus monkeys will enable us to develop a unique prototypic animal production program for the creation of MHC-defined and genetically-identical monkeys for vaccine research.

AB - One of the best animal approaches for testing HIV vaccines is the challenge of vaccinated rhesus macaques with SHIV or SIV. Production of rhesus macaques in which all of the MHC class I and II alleles are known represents an opportunity to characterize the entire immune response to SIV and should be an invaluable resource for understanding pathogenesis and vaccine-induced immune responses. Unfortunately, there are few MHC-defined rhesus macaques available for vaccine research. Selective breeding supports the production of limited numbers of macaques that express particular MHC class I alleles. If both parents express the allele of interest, only three quarters of the offspring will express the same allele. However, assisted reproductive technologies, such as in vitro fertilization (IVF) and embryo transfer, can be used for production of MHC-defined macaques, expressing multiple MHC class I and II molecules for which SIV peptides, tetramers and ELISPOT assays exist. Here, we report the birth of MHC-defined rhesus monkeys produced by assisted reproductive technology. Continued improvements in assisted reproductive technologies in rhesus monkeys will enable us to develop a unique prototypic animal production program for the creation of MHC-defined and genetically-identical monkeys for vaccine research.

KW - Assisted reproductive technology

KW - MHC-defined monkeys

KW - SIV vaccine

UR - http://www.scopus.com/inward/record.url?scp=0035851381&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035851381&partnerID=8YFLogxK

U2 - 10.1016/S0264-410X(01)00336-X

DO - 10.1016/S0264-410X(01)00336-X

M3 - Article

VL - 20

SP - 603

EP - 607

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 3-4

ER -